# A Study of KW-3357 in Congenital Antithrombin Deficiency

> **NCT00938288** · PHASE1 · COMPLETED · sponsor: **Kyowa Kirin Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Congenital Antithrombin Deficiency

## Interventions

- **DRUG:** KW-3357

## Key facts

- **NCT ID:** NCT00938288
- **Lead sponsor:** Kyowa Kirin Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-12-22
- **Final completion:** 2011-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2024-10-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938288, "A Study of KW-3357 in Congenital Antithrombin Deficiency". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00938288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*